Last reviewed · How we verify

Oxygen + Midazolam

Unity Health Toronto · FDA-approved active Small molecule

Oxygen increases blood oxygen saturation while midazolam provides sedation and anxiolysis via GABA-A receptor modulation.

Oxygen increases blood oxygen saturation while midazolam provides sedation and anxiolysis via GABA-A receptor modulation. Used for Procedural sedation and anxiolysis during medical procedures, Maintenance of oxygenation during sedated procedures.

At a glance

Generic nameOxygen + Midazolam
SponsorUnity Health Toronto
Drug classSupportive care combination (oxygen + benzodiazepine)
TargetGABA-A receptor (midazolam component)
ModalitySmall molecule
Therapeutic areaAnesthesia/Procedural Sedation
PhaseFDA-approved

Mechanism of action

This is a supportive care combination used during medical procedures. Oxygen ensures adequate oxygenation and prevents hypoxemia, while midazolam, a benzodiazepine, binds to GABA-A receptors in the central nervous system to produce sedation, anxiolysis, and amnesia. Together they enable safe procedural sedation with maintained oxygenation.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: